Skeletal Disorder TRIZ Cases
- NRTI Osteoarthritis Treatment for Cartilage Degeneration Control
Systemic NRTI treatment addresses osteoarthritis by reducing inflammation and cartilage degeneration while avoiding joint replacement surgery.
- Fibroblast Pretreatment With Platelet-Rich Plasma for Disc Regeneration
Platelet-rich plasma and FGF-pretreated fibroblasts boost disc matrix synthesis and curb degeneration in spinal disc repair.
- Humanized Anti-CD40 Antibody Dosing for Refractory Rheumatoid Arthritis
Flexible humanized anti-CD40 antibody dosing helps treat rheumatoid arthritis when JAKi or DMARD response is inadequate or intolerable.
- Yeast Shell Oral Delivery for Targeted Macrophage Immunomodulation
Yeast shells enable oral macrophage targeting via Dectin-1 while improving GI stability and reducing inflammatory side effects in RA.
- Low-Dose Subcutaneous Anti-CD38 Antibodies With Fewer Blood Cell Side Effects
Low-dose subcutaneous anti-CD38 antibodies maintain efficacy while reducing red-blood-cell-related side effects and infusion burden.
- Liriodendron Chinense Extract for Uric Acid Nephropathy Relief
Alcohol-extracted Liriodendron chinense lowers serum uric acid and helps relieve renal dilation, glomerulosclerosis, and fibrosis.
- Scaffold-Free 3D Disc Tissue for Durable Engraftment
Scaffold-free 3D tissue from synovium-derived mesenchymal stem cells improves disc graft engraftment and supports longer-lasting regeneration.
- CCL5 Stem Cell Mobilization Composition for Faster Engraftment
CCL5 with GROβ and AMD3100 mobilizes hematopoietic stem cells into peripheral blood and improves engraftment after transplantation.
- Fermented Morinda Citrifolia Extract for Osteoarthritis Inflammation
Fermented Morinda citrifolia extract uses Lactobacillus plantarum fermentation to inhibit inflammatory and cartilage-degrading factors in osteoarthritis.
- Anti-Vaspin Nanobody Composition for Osteoarthritis Cartilage Protection
A high-affinity anti-vaspin nanobody blocks cartilage degradation in osteoarthritis by targeting cryptic epitopes inaccessible to conventional antibodies.
- Anti-CD45 ADC Conditioning for Lower-Toxicity AutoHSCT
Anti-CD45 antibodies and ADCs selectively deplete CD45+ cells to enable lower-toxicity autoHSCT conditioning and broader autoimmune patient eligibility.
- Biodegradable Copolymer Joint Depot for Synovial Drug Retention
A triblock-diblock biodegradable copolymer depot morselizes in joints to extend synovial drug retention and tune release over time.
- Allogeneic Chondrocyte Collagen Implant for Single-Procedure Cartilage Repair
Cultured allogeneic chondrocytes on a resorbable collagen membrane repair chondral defects in one procedure and help prevent further cartilage degradation.
- Hydrogel Hybrid Bone Filler for Localized Alendronate Release
Localized alendronate delivery in a hydrogel-silica bone filler improves retention and release control while reducing systemic side effects.
- Morselizing Copolymer Joint Depot for Synovial Drug Targeting
Mechanical morselization of a triblock-diblock biodegradable joint depot improves synovial retention and modulates drug release.
- SPRF Chondrocyte Expansion Without Redifferentiation Drift
SPRF from platelet-rich fibrin boosts chondrocyte proliferation while limiting redifferentiation and improving consistency over PRP.
- Non-Alginate Hydrogel Microparticles With Tunable Degradation
Covalently crosslinked non-alginate hydrogel microparticles improve cell encapsulation biocompatibility while enabling tunable degradation and sustained release.
- Muscle-Derived Progenitor Matrix for Bone Graft Cell Survival
A biocompatible SIS matrix helps muscle-derived progenitor cells survive, integrate, and augment bone while limiting migration and inflammation.
- rAAV miRNA Delivery for Osteoblast and Osteoclast Regulation
rAAV delivery of miR-214-3p inhibitors and miR-34a-5p boosts osteogenesis while limiting osteoclastogenesis in osteoporosis.